BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 22951353)

  • 1. HIV infection and obesity: where did all the wasting go?
    Tate T; Willig AL; Willig JH; Raper JL; Moneyham L; Kempf MC; Saag MS; Mugavero MJ
    Antivir Ther; 2012; 17(7):1281-9. PubMed ID: 22951353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada.
    Koethe JR; Jenkins CA; Lau B; Shepherd BE; Justice AC; Tate JP; Buchacz K; Napravnik S; Mayor AM; Horberg MA; Blashill AJ; Willig A; Wester CW; Silverberg MJ; Gill J; Thorne JE; Klein M; Eron JJ; Kitahata MM; Sterling TR; Moore RD;
    AIDS Res Hum Retroviruses; 2016 Jan; 32(1):50-8. PubMed ID: 26352511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of being Overweight and Obese HIV-infected persons, before and after 24 months on early ART in the ANRS 12136 Temprano Trial.
    Guehi C; Badjé A; Gabillard D; Ouattara E; Koulé SO; Moh R; Ekouevi D; Ahibo H; N'Takpé JB; Menan GK; Deschamps N; Lecarrou J; Eholié S; Anglaret X; Danel C
    AIDS Res Ther; 2016; 13():12. PubMed ID: 26925155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-Infected Women Gain More Weight than HIV-Infected Men Following the Initiation of Antiretroviral Therapy.
    Bares SH; Smeaton LM; Xu A; Godfrey C; McComsey GA
    J Womens Health (Larchmt); 2018 Sep; 27(9):1162-1169. PubMed ID: 29608129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study.
    Achhra AC; Mocroft A; Reiss P; Sabin C; Ryom L; de Wit S; Smith CJ; d'Arminio Monforte A; Phillips A; Weber R; Lundgren J; Law MG;
    HIV Med; 2016 Apr; 17(4):255-68. PubMed ID: 26216031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive effects of body mass index on immune reconstitution among HIV-infected HAART users in China.
    Li X; Ding H; Geng W; Liu J; Jiang Y; Xu J; Zhang Z; Shang H
    BMC Infect Dis; 2019 May; 19(1):373. PubMed ID: 31046702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An optimal body mass index range associated with improved immune reconstitution among HIV-infected adults initiating antiretroviral therapy.
    Koethe JR; Jenkins CA; Shepherd BE; Stinnette SE; Sterling TR
    Clin Infect Dis; 2011 Nov; 53(9):952-60. PubMed ID: 21946189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tale of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia.
    Amorosa V; Synnestvedt M; Gross R; Friedman H; MacGregor RR; Gudonis D; Frank I; Tebas P
    J Acquir Immune Defic Syndr; 2005 Aug; 39(5):557-61. PubMed ID: 16044007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weight gain among treatment-naïve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada.
    Bourgi K; Jenkins CA; Rebeiro PF; Palella F; Moore RD; Altoff KN; Gill J; Rabkin CS; Gange SJ; Horberg MA; Margolick J; Li J; Wong C; Willig A; Lima VD; Crane H; Thorne J; Silverberg M; Kirk G; Mathews WC; Sterling TR; Lake J; Koethe JR;
    J Int AIDS Soc; 2020 Apr; 23(4):e25484. PubMed ID: 32294337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short communication: from wasting to obesity: initial antiretroviral therapy and weight gain in HIV-infected persons.
    Lakey W; Yang LY; Yancy W; Chow SC; Hicks C
    AIDS Res Hum Retroviruses; 2013 Mar; 29(3):435-40. PubMed ID: 23072344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased body mass index does not alter response to initial highly active antiretroviral therapy in HIV-1-infected patients.
    Tedaldi EM; Brooks JT; Weidle PJ; Richardson JT; Baker RK; Buchacz K; Moorman AC; Wood KC; Holmberg SD;
    J Acquir Immune Defic Syndr; 2006 Sep; 43(1):35-41. PubMed ID: 16885779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity following ART initiation is common and influenced by both traditional and HIV-/ART-specific risk factors.
    Bakal DR; Coelho LE; Luz PM; Clark JL; De Boni RB; Cardoso SW; Veloso VG; Lake JE; Grinsztejn B
    J Antimicrob Chemother; 2018 Aug; 73(8):2177-2185. PubMed ID: 29722811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends and risk factors for obesity among HIV positive Nigerians on antiretroviral therapy.
    Ezechi LO; Musa ZA; Otobo VO; Idigbe IE; Ezechi OC
    Ceylon Med J; 2016 Jun; 61(2):56-62. PubMed ID: 27423745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight change after antiretroviral therapy and mortality.
    Yuh B; Tate J; Butt AA; Crothers K; Freiberg M; Leaf D; Logeais M; Rimland D; Rodriguez-Barradas MC; Ruser C; Justice AC
    Clin Infect Dis; 2015 Jun; 60(12):1852-9. PubMed ID: 25761868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight status and associated factors among HIV infected people on antiretroviral therapy in rural Dikgale, Limpopo, South Africa.
    Mashinya F; Alberts M; Colebunders R; Van Geertruyden JP
    Afr J Prim Health Care Fam Med; 2016 Nov; 8(1):e1-e8. PubMed ID: 28155318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal association between BMI at diagnosis and HIV disease progression.
    Johnson KD; Cai B; Duffus W; White K; Smieja M; Divya A; Merchant AT
    AIDS Behav; 2014 Nov; 18(11):2249-57. PubMed ID: 24880700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body mass index and noninfectious comorbidity in HIV-positive patients commencing antiretroviral therapy in Zimbabwe.
    Bleasel JM; Heron JE; Shamu T; Chimbetete C; Dahwa R; Gracey DM
    HIV Med; 2020 Nov; 21(10):674-679. PubMed ID: 32892487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
    Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
    Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case-control study.
    Madelain V; Le MP; Champenois K; Charpentier C; Landman R; Joly V; Yeni P; Descamps D; Yazdanpanah Y; Peytavin G
    J Antimicrob Chemother; 2017 Apr; 72(4):1137-1146. PubMed ID: 28065890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral Therapy Anchor-based Trends in Body Mass Index Following Treatment Initiation Among Military Personnel with HIV.
    Kline MDA; Daniels C; Xu X; Sunil T; Ganesan A; Agan BK; Colombo RE; Kronmann KC; Blaylock JM; Okulicz JF; Markelz AE
    Mil Med; 2021 Feb; 186(3-4):279-285. PubMed ID: 33128552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.